---
title: "GW PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/a659e26b-83cf-52dd-8ec3-4369a98e5ce8
json: https://whiteintel.dev/api/public/dossier/a659e26b-83cf-52dd-8ec3-4369a98e5ce8
identifier: oo:GB-COH-04160917
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GW PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-04160917`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/a659e26b-83cf-52dd-8ec3-4369a98e5ce8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/a659e26b-83cf-52dd-8ec3-4369a98e5ce8  

## Cross-source identity

The same real-world entity, resolved across sources:

- **GW PHARMACEUTICALS LIMITED** — GLEIF · `lei:213800ISBN5CNUZMHZ39` — https://whiteintel.dev/entity/bceada75-cc47-5e12-875f-ec4e2bcdf899

## Ownership & control

### Owners / controllers

- **JAZZ PHARMACEUTICALS UK HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/c5b704d6-d5fd-55e7-867f-a0ad6f667a04

### Holdings / subsidiaries

- **JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/379e3412-fbbc-5029-8f4b-507865909899
- **GW UK SERVICES LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/58d26644-372b-532a-bd06-b37a38f7f436
- **JAZZ PHARMACEUTICALS RESEARCH UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/46daeae4-7ab8-5512-bbab-08f009d15963
- **GW UK SERVICES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/58d26644-372b-532a-bd06-b37a38f7f436
- **JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/379e3412-fbbc-5029-8f4b-507865909899

### UBO chain (walk to the ultimate owner)

A **2-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `04160917`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2001-02-15
- **Registered office:** 80 Charlotte Street, London, W1T 4DF, England
- **SIC:** 86900

### Officers

- PATEL, Alkesh — secretary · appointed 2024-04-03
- FLANAGAN, Amanda — director · Irish · appointed 2025-02-10
- SPACKMAN, David James — director · British · appointed 2023-01-13
- DOODY, Aislinn Jane — secretary · appointed 2023-01-13 · resigned 2024-04-03
- GEORGE, Adam David — secretary · British · appointed 2008-03-05 · resigned 2020-12-18
- HILLHOUSE, Robert James — secretary · British · appointed 2001-02-15 · resigned 2001-05-31
- LAUGHTON, Jonathan Michael — secretary · British · appointed 2001-05-31 · resigned 2008-03-05
- SNYDER, Douglas — secretary · appointed 2020-12-18 · resigned 2021-08-12
- WARD, Iain — secretary · appointed 2021-08-12 · resigned 2023-01-13
- ARMISSOGLIO ÉP. LEPELLETIER, Nelly Alexandra — director · French · appointed 2023-01-13 · resigned 2025-02-10
- BROWN, Cabot — director · American · appointed 2013-02-19 · resigned 2021-05-05
- BROWN, Cabot — director · American · appointed 2013-01-18 · resigned 2013-01-18
- CAMPBELL, Adrian — director · British · appointed 2021-05-05 · resigned 2023-01-01
- FORREST, Richard George — director · British · appointed 2007-03-15 · resigned 2013-01-18
- GANGOLLI, Julian Steatham — director · American · appointed 2015-07-16 · resigned 2017-02-13
- GEORGE, Adam David — director · British · appointed 2012-06-01 · resigned 2017-02-13
- GOVER, Justin David — director · British · appointed 2001-03-05 · resigned 2021-05-05
- GRYSKA, David — director · American · appointed 2020-09-09 · resigned 2021-05-05
- GUY, Geoffrey William, Dr — director · British · appointed 2001-03-05 · resigned 2021-05-05
- KIRK, David Francis — director · British · appointed 2001-09-10 · resigned 2012-06-01

### Beneficial owners (Persons with Significant Control)

- [Jazz Pharmaceuticals Uk Holdings Limited](https://whiteintel.dev/entity/c5b704d6-d5fd-55e7-867f-a0ad6f667a04) — 75–100% shares · corporate PSC · United Kingdom — since 2021-05-05

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/04160917
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/04160917

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **GW PHARMACEUTICALS LIMITED** — https://whiteintel.dev/entity/a659e26b-83cf-52dd-8ec3-4369a98e5ce8 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GW PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/a659e26b-83cf-52dd-8ec3-4369a98e5ce8 · Structured JSON: https://whiteintel.dev/api/public/dossier/a659e26b-83cf-52dd-8ec3-4369a98e5ce8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._